November 8, 2017 01:29 PM ESTUpdated December 18, 12:15 AM
People

Ex­o­dus of Ex-Googlers at Sil­i­con Val­ley's sex­i­est biotech star­tups

Brittany Meiling

A cu­ri­ous num­ber of high pro­file ex-Googlers are bail­ing from Sil­i­con Val­ley’s sex­i­est biotech star­tups, with many end­ing up in de­cid­ed­ly more tra­di­tion­al bio­phar­ma roles …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times